Drug intelligence / Profile preview

Daphne Continu

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

**Daphne Continu** is a low-dose combined oral contraceptive containing **cyproterone acetate (2 mg)** and **ethinylestradiol**. It functions as an anti-androgen and estrogen combination, primarily used for contraception, particularly in women with androgen-dependent conditions such as severe acne, hirsutism, alopecia, and seborrhea. The cyproterone acetate component acts as a potent androgen receptor antagonist, blocking testosterone and dihydrotestosterone effects, while also providing progestational activity; ethinylestradiol enhances contraceptive efficacy. It is indicated when other treatments fail, with recommendations to use the lowest effective dose due to risks like meningioma at higher cumulative exposures. Contraindicated in meningioma history, pregnancy, and certain cardiovascular or liver conditions.[5][6]

Brand names
Daphne ContinuDaphne
Other names
Daphne
02

Targets

AR (Adrenergic receptors)PR (Progesterone receptor)LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)

Beyond the preview

Go deeper on Daphne Continu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daphne Continu.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call